| 2001 |
Pelletier J-P, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. June 2001;44(6):1237-1247. |
29 |
29 |
| 2006 |
Bingham CO III, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier J-P, Raynauld J-P, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. November 2006;54(11):3494-3507. |
21 |
20 |
| 2022 |
Teoli A, Cloutier-Gendron M, Ho SYK, Gu S, Pelletier J-P, Martel-Pelletier J, Robbins SM. The relationship between knee loading during gait and cartilage thickness in nontraumatic and posttraumatic knee osteoarthritis. J Orthop Res. August 2022;40(8):1778-1786. |
0 |
0 |
| 2011 |
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. January 2011;7(1):33-42. |
28 |
28 |
| 2006 |
Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Pelletier J-P, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. January 2006;14(1):13-29. |
79 |
79 |